Sensus Healthcare (SRTS)
(Delayed Data from NSDQ)
$6.27 USD
-0.07 (-1.10%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $6.27 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Brokerage Reports
Sensus Healthcare, Inc. [SRTS]
Reports for Purchase
Showing records 41 - 60 ( 102 total )
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Record 4Q21 Sales Lead to Profitability; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Exclusive Distribution Agreement Inked for TransDermal Infusion System; Reiterate Buy; Raising PT to $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
3Q21 Recap - Robust Backlog Should Drive Strong 4Q21 Results
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Positive Earnings in 3Q21; Reiterate Buy; Raising PT to $9
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
2Q21 Recap - Strong Momentum Should Carry into 2H21
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Top and Bottom-Line Beat in 2Q21; Sculptura Data Nears; Raising PT to $7
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
1Q21 Financials; Revenue In-Line, Lower-Than-Projected Net Loss; Reit Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Sales Recovery Starts in 4Q20; Reiterate Buy; Raising PT to $6
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
4Q20 Recap - Upside on Top and Bottom Lines; PT to $6
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
CMS Increases Reimbursement for Superficial Radiation Therapy; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Superficial Radiation Therapy Shown to Lower Keloid Recurrence; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
3Q20 Recap - Tightening Belts for 2022 Breakout
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: Sensus Healthcare, Inc.
Industry: Medical - Instruments
3Q20 Financial Results Reported; Reiterate Buy; Lowering PT to $4
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y